VITL Vital Farms, Inc.
Food and Kindred Products · Nasdaq · SEC CIK 1579733 · Fiscal year ends 12/27
Financial factors as of 2026-09-27 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.2%
TTM net income YoY-137.5%
TTM EPS YoY-142.4%
Revenue 3-yr CAGR18.8%
Net income 3-yr CAGR—
Margins
Gross margin24.4%
Operating margin-3.8%
Net margin-3.0%
FCF margin-18.5%
EBITDA margin-2.4%
Returns
ROE-7.4%
ROA-4.3%
ROIC (approx.)-8.2%
Asset turnover1.42x
Leverage & solvency
Liabilities / assets50.8%
Debt / equity0.42x
Current ratio1.56x
Interest coverage-7.67x
Cash quality & payout
Operating cash flow / net income2.14x
Accruals ratio4.9%
Payout ratio—
Capex / revenue12.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-28 | FY20242024-12-29 |
|---|---|---|
| Income statement | ||
| Revenue | $759.44M | $606.31M |
| Cost of revenue | $473.76M | $376.38M |
| Gross profit | $285.68M | $229.93M |
| SG&A expense | $159.43M | $133.94M |
| Operating income | $88.37M | $63.55M |
| Interest expense | $874,000 | $1.01M |
| Pretax income | $91.26M | $67.54M |
| Income tax | $24.98M | $14.15M |
| Net income | $66.28M | $53.39M |
| EBITDA | $97.63M | $72.81M |
| EPS (basic) | 1.49 | 1.25 |
| EPS (diluted) | 1.44 | 1.18 |
| Weighted avg. shares (diluted) | 46.02M | 45.13M |
| Balance sheet | ||
| Cash & equivalents | $48.83M | $150.60M |
| Receivables | $67.85M | $54.34M |
| Inventory | $66.50M | $23.67M |
| Current assets | $262.55M | $246.04M |
| PP&E, net | $160.60M | $84.52M |
| Goodwill | $3.86M | $3.86M |
| Total assets | $518.74M | $359.33M |
| Current liabilities | $121.58M | $78.53M |
| Short-term debt | $0 | — |
| Long-term debt | $0 | — |
| Total debt | $0 | — |
| Total liabilities | $167.48M | $90.03M |
| Shareholders' equity | $351.26M | $269.30M |
| Net debt | -$48.83M | — |
| Shares outstanding | 44.80M | 44.04M |
| Cash flow statement | ||
| Operating cash flow | $33.72M | $64.82M |
| Capital expenditure | $81.95M | $28.65M |
| Free cash flow | -$48.23M | $36.18M |
| Investing cash flow | -$134.25M | -$7.03M |
| Financing cash flow | -$1.23M | $8.65M |
| Depreciation & amortization | $9.25M | $9.26M |
| Stock-based compensation | $12.39M | $10.27M |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.